(Total Views: 700)
Posted On: 03/26/2021 8:04:40 PM
Post# of 148908
Good evening good people,
As many of you here may recall, I am a longtime reader/follower/aficionado/investor of this site and CYDY.
The price action this week was particularly amusing.
The week began at $2.45, visited the $2.30s on Tuesday, the $2.20s on Wednesday, the high teens on Thursday and capitulated its teen status as of this afternoon's closing print, at $2.12. The humor of these closing prints for someone like me (given my line of work) is beyond humorous. I think the term the kids nowadays use is 'tryhard'. The job has been done. The closing mark for the last full week of March is at the closing low for the entire month. Those who are short will receive a magnificent mark to market from their clearing firms and will have wonderful request for funds met with a maximum credit available from their account (golf clap). Next Mon/Tues/Wed will be quite dramatic. IF Nader is to be believed, we will be post 2 full weeks for a conditional EUA request to THEE FDA.
Time is a very funny thing, as it passes the hard facts of life stay fixed, and what appeared initially to be mutable tends to become either dismissed wholly or proven immutable. My favorite historical examples of this phenomena being a. Gravity, b. Relativity, c. Quantum Mechanics (some of the more scientific leaning readers here might observe my form of humor). Smooth versus lumpy seems to be the ride most investors prefer. Unfortunately, the market is rarely this kind. However, it could be worse. Really.
Imagine if you will that you are THEE FDA. The world is afflicted with a global pandemic. You, the arbiter of all things cutting edge medical science and establishment are tasked with stanching the pandemic as it afflicts the most technological advanced country that has ever existed, which also happens to be the only global superpower left after a decades long cold war. Fifty six weeks in all you have to show to the world is the world's leading death and infection count and 3 vaccines of which no one is quite sure of their longterm side effects nor efficacy in treating or preventing S/C COVID-19 appearing within new variants that are popping up with a frequency that make the game of Whack-A-Mole seem tame. You have granted EUA status to 5 biologic drugs within the past 56 weeks. At week 57 you face the hard cold reality that 3 of the 5 have failed to produce ANY life saving benefit. To make matters worse, 2 of the products granted EUA status have been revoked. As you approach week 58 you quietly release the following:
*** The US government and Eli Lilly agreed to halt all distribution of the company’s Covid-19 monoclonal antibody bamlanivimab as of Wednesday due to the “sustained increase” of coronavirus variants in the US.
All treatment delivery sites will continue to be able to order Lilly’s combo Covid-19 treatment of bamlanivimab and etesevimab, to be administered together, or Regeneron’s antibody cocktail, the assistant secretary for preparedness and response (ASPR) and FDA said. Both of the treatments from Lilly and Regeneron have proven to be useful among people who have Covid-19 but are not hospitalized.
“We recognize the U.S. government has made the decision to no longer allow direct ordering of bamlanivimab alone due to concerns about the prevalence of the California (B.1.427/B.1.429) and New York (B.1.526) variants of SARS-CoV-2. The U.S. government has enabled direct ordering of bamlanivimab and etesevimab together as well as etesevimab alone, to pair with bamlanivimab that sites of care have on hand,” Lilly said in an emailed statement.
*** ENPOINTS NEWS 3/25/21 10:14AM EDT
(all while simultaneously trumpeting yet a "new" MAB from this stellar BP within the 24hr news cycle)
All as we get reports such as https://abcnews.go.com/US/variants-account-51...d=76367582
Meanwhile, here in the cheaper-by-the-day seats, we sit with a biologic drug proven safe, near 30% efficacious in treating S/C COVID-19 patients over SOC that is "variant agnostic". Oh yes, Miami Beach closed the causeways and instituted a forced curfew for its unmasked spring breakers when we were at $2.45. Who knew?!?!
Good people, we may be short on upticks but we certainly are not short on THEE FDA induced maudlin humor.
Bon chance,
TSOV
As many of you here may recall, I am a longtime reader/follower/aficionado/investor of this site and CYDY.
The price action this week was particularly amusing.
The week began at $2.45, visited the $2.30s on Tuesday, the $2.20s on Wednesday, the high teens on Thursday and capitulated its teen status as of this afternoon's closing print, at $2.12. The humor of these closing prints for someone like me (given my line of work) is beyond humorous. I think the term the kids nowadays use is 'tryhard'. The job has been done. The closing mark for the last full week of March is at the closing low for the entire month. Those who are short will receive a magnificent mark to market from their clearing firms and will have wonderful request for funds met with a maximum credit available from their account (golf clap). Next Mon/Tues/Wed will be quite dramatic. IF Nader is to be believed, we will be post 2 full weeks for a conditional EUA request to THEE FDA.
Time is a very funny thing, as it passes the hard facts of life stay fixed, and what appeared initially to be mutable tends to become either dismissed wholly or proven immutable. My favorite historical examples of this phenomena being a. Gravity, b. Relativity, c. Quantum Mechanics (some of the more scientific leaning readers here might observe my form of humor). Smooth versus lumpy seems to be the ride most investors prefer. Unfortunately, the market is rarely this kind. However, it could be worse. Really.
Imagine if you will that you are THEE FDA. The world is afflicted with a global pandemic. You, the arbiter of all things cutting edge medical science and establishment are tasked with stanching the pandemic as it afflicts the most technological advanced country that has ever existed, which also happens to be the only global superpower left after a decades long cold war. Fifty six weeks in all you have to show to the world is the world's leading death and infection count and 3 vaccines of which no one is quite sure of their longterm side effects nor efficacy in treating or preventing S/C COVID-19 appearing within new variants that are popping up with a frequency that make the game of Whack-A-Mole seem tame. You have granted EUA status to 5 biologic drugs within the past 56 weeks. At week 57 you face the hard cold reality that 3 of the 5 have failed to produce ANY life saving benefit. To make matters worse, 2 of the products granted EUA status have been revoked. As you approach week 58 you quietly release the following:
*** The US government and Eli Lilly agreed to halt all distribution of the company’s Covid-19 monoclonal antibody bamlanivimab as of Wednesday due to the “sustained increase” of coronavirus variants in the US.
All treatment delivery sites will continue to be able to order Lilly’s combo Covid-19 treatment of bamlanivimab and etesevimab, to be administered together, or Regeneron’s antibody cocktail, the assistant secretary for preparedness and response (ASPR) and FDA said. Both of the treatments from Lilly and Regeneron have proven to be useful among people who have Covid-19 but are not hospitalized.
“We recognize the U.S. government has made the decision to no longer allow direct ordering of bamlanivimab alone due to concerns about the prevalence of the California (B.1.427/B.1.429) and New York (B.1.526) variants of SARS-CoV-2. The U.S. government has enabled direct ordering of bamlanivimab and etesevimab together as well as etesevimab alone, to pair with bamlanivimab that sites of care have on hand,” Lilly said in an emailed statement.
*** ENPOINTS NEWS 3/25/21 10:14AM EDT
(all while simultaneously trumpeting yet a "new" MAB from this stellar BP within the 24hr news cycle)
All as we get reports such as https://abcnews.go.com/US/variants-account-51...d=76367582
Meanwhile, here in the cheaper-by-the-day seats, we sit with a biologic drug proven safe, near 30% efficacious in treating S/C COVID-19 patients over SOC that is "variant agnostic". Oh yes, Miami Beach closed the causeways and instituted a forced curfew for its unmasked spring breakers when we were at $2.45. Who knew?!?!
Good people, we may be short on upticks but we certainly are not short on THEE FDA induced maudlin humor.
Bon chance,
TSOV
(17)
(2)Scroll down for more posts ▼
